Characteristics of A20 gene polymorphisms and clinical significance in patients with rheumatoid arthritis
Open Access
- 5 July 2015
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 13 (1) , 1-10
Abstract
There are a number of studies regarding to the susceptibility of A20 SNPs in rheumatoid arthritis (RA); however, a few of these studies have shown an association between polymorphisms in the A20 gene and RA risk in the Chinese population. The aim of this study was to investigate the characteristics of A20 gene polymorphisms, the association between polymorphisms and clinical significance in Chinese RA patients. PCR and sequencing were used to identify A20 gene polymorphisms in peripheral blood mononuclear cells (PBMCs) (50 cases), synovial fluid (11 cases) from RA patients and PBMCs from 30 healthy individuals. Quantitative Real-time PCR (qRT-PCR) was used to analyze the A20 mRNA expression in 38 RA patients and 40 healthy individuals. Pearson’s Chi square test and two independent-samples Wilcoxon tests were used for statistical analysis. Eight single nucleotide polymorphisms (SNPs) (rs5029937, rs3799491, rs598493, rs2307859, rs146534657, rs2230926, rs661561, and rs582757) were identified in PBMCs of RA patients. One new mutation (14284 T > A) was identified in synovial fluid mononuclear cells from one RA case. rs146534657 was identified for the first time in two RA cases. Patients with rs146534657 (12411 A > G, Asn102Ser) AG genotype or rs2230926 (12486 T > G, Phe127Cys) TG genotype had poor outcome. Significantly lower A20 mRNA expression was found in PBMCs from RA patients compared with healthy individuals (p < 0.001). There was a higher A20 mRNA expression in RA patients with rs2230926 TG genotype and rs146534657 AG genotype (11.56 ± 7.39) than patients with rs2230926 TT genotype and rs146534657 AA genotype (5.63 ± 4.37) (p = 0.031). Significantly lower A20 expression was found in RA patients. The polymorphisms of A20 were characterized in RA patients. We detected rs146534657 for the first time and identified a new A20 mutation (14284 T > A). A20 rs2230926 TG genotype and rs146534657 AG genotype may be related to poor outcome in RA patients.Keywords
This publication has 38 references indexed in Scilit:
- Different amounts of protein-bound citrulline and homocitrulline in foot joint tissues of a patient with anti-citrullinated protein antibody positive erosive rheumatoid arthritisJournal of Translational Medicine, 2013
- Mutations increased overexpression of Notch1 in T-cell acute lymphoblastic leukemiaCancer Cell International, 2012
- Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseasesGenes & Immunity, 2011
- Tyrosine kinases in rheumatoid arthritisJournal of Inflammation, 2011
- Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markersAnnals of the Rheumatic Diseases, 2010
- The Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents AutoimmunityImmunity, 2010
- Association of the 6q23 region with the rate of joint destruction in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2010
- Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23Human Molecular Genetics, 2009
- A20: Central Gatekeeper in Inflammation and ImmunityJournal of Biological Chemistry, 2009
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988